PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 208 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,445,000 | +113.8% | 45,145 | +68.5% | 0.64% | +67.8% |
| Q3 2020 | $1,611,000 | -17.3% | 26,798 | -27.8% | 0.38% | -11.4% |
| Q2 2020 | $1,949,000 | -35.0% | 37,137 | -4.8% | 0.43% | +9.9% |
| Q4 2015 | $2,997,000 | +64.0% | 39,026 | +89.4% | 0.39% | +53.7% |
| Q4 2014 | $1,827,000 | +3.2% | 20,604 | +12.8% | 0.26% | -29.2% |
| Q3 2014 | $1,770,000 | -16.9% | 18,264 | -21.3% | 0.36% | -10.9% |
| Q2 2014 | $2,131,000 | -11.7% | 23,201 | -32.7% | 0.40% | -7.1% |
| Q1 2014 | $2,412,000 | +2.8% | 34,455 | -15.6% | 0.44% | +3.6% |
| Q4 2013 | $2,347,000 | -20.7% | 40,829 | -33.6% | 0.42% | -28.8% |
| Q3 2013 | $2,958,000 | +57.8% | 61,515 | -4.8% | 0.59% | +45.0% |
| Q2 2013 | $1,875,000 | – | 64,641 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |